Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product


Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance

See the rest here:
Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product

Related Posts